Molecular pathology in diagnosis and prognostication of head and neck tumors




Skálová Alena, Bradová Martina, Michal Michael, Mosaieby Elaheh, Klubíčková Natálie, Vaněček Tomáš, Leivo Ilmo

PublisherSpringer Science and Business Media Deutschland GmbH

2024

Virchows Archiv

Virchows Archiv

484

2

215

231

0945-6317

1432-2307

DOIhttps://doi.org/10.1007/s00428-023-03731-2

https://link.springer.com/article/10.1007/s00428-023-03731-2

https://research.utu.fi/converis/portal/detail/Publication/386849265



Classification of head and neck tumors has evolved in recent decades including a widespread application of molecular testing in tumors of the salivary glands, sinonasal tract, oropharynx, nasopharynx, and soft tissue. Availability of new molecular techniques allowed for the definition of multiple novel tumor types unique to head and neck sites. Moreover, the expanding spectrum of immunohistochemical markers facilitates a rapid identification of diagnostic molecular abnormalities. As such, it is currently possible for head and neck pathologists to benefit from a molecularly defined classifications, while making diagnoses that are still based largely on histopathology and immunohistochemistry. This review highlights some principal molecular alterations in head and neck neoplasms presently available to assist pathologists in the practice of diagnosis, prognostication and prediction of response to treatment. © 2024, The Author(s).

Last updated on 2025-25-03 at 13:57